ALT GPT (BIOLABO ALT GPT )
- UID
- IMP/IVD/2023/000051_db5f3206aca305f7eb1bf429ed557d05_cafa7011139aeef407c84539cb4809e9
- Device class
- Class B
- Brand name
- BIOLABO ACID CALCIUM Arsenazo III Method
- License holder
- Wheecon Instruments Private Limited
- Approving authority
- CDSCO
- Product information
- ALT is present in very high amounts in liver and kidney, and in smaller amounts in skeletal muscle and heart. Although serum levels of both AST and ALT become elevated whenever diseases process affecting liver cells integrity, ALT is the more liver-specific enzyme. A serum elevation of ALT activity is rarely observed in conditions other than parenchymal liver disease (BIOLABO ACID CALCIUM Arsenazo III Method). Moreover, its elevation persists longer than do those of AST activity. Measurement of both AST and ALT has some value in distinguishing hepatitis from other parenchymal lesions
ALT GPT (BIOLABO ALT GPT ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000051_db5f3206aca305f7eb1bf429ed557d05_cafa7011139aeef407c84539cb4809e9. This device is marketed under the brand name BIOLABO ACID CALCIUM Arsenazo III Method. The license holder is Wheecon Instruments Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.